Stocks TelegraphStocks Telegraph
Stock Ideas

PTPI Financial Statements and Analysis

NASDAQ : PTPI

Petros Pharmaceuticals, Inc.

$0.31
-0.0106-3.31%
At Close 4:00 PM
61.06
BESG ScoreESG Rating

PTPI FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

PTPI Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue1.576M1.421M1.389M-364.25K1.675M
cost of revenue287.005K329.11K331.831K158.147K408.475K
gross profit1.289M1.092M1.057M-522.397K1.266M
gross profit ratio0.8180.7680.7611.4340.756
research and development expenses588.355K368.798K1.556M834.334K389.093K
general and administrative expenses00000
selling and marketing expenses00000
selling general and administrative expenses2.301M2.287M2.711M2.879M2.002M
other expenses0717.838K386.008K03.273M
operating expenses2.89M3.373M4.653M4.516M5.664M
cost and expenses3.916M3.702M4.985M4.674M6.073M
interest income75.817K119.391K151.819K227.589K168.481K
interest expense158.73K114.512K120.209K125.821K-131.351K
depreciation and amortization768.26K754.667K753.527K934.794K826.795K
ebitda-1.294M207.153K-1.289M-3.876M-3.98M
ebitda ratio-0.8210.146-1.12710.642-2.377
operating income-2.34M-2.281M-3.928M-5.039M-4.807M
operating income ratio-1.484-1.605-2.82913.833-2.87
total other income expenses net119.087K1.619M1.766M5.255M257.133K
income before tax-2.221M-662.026K-2.163M318.15K-4.55M
income before tax ratio-1.409-0.466-1.557-0.873-2.717
income tax expense005.864M125.821K0
net income-2.221M-662.026K-8.027M318.15K-4.55M
net income ratio-1.409-0.466-5.78-0.873-2.717
eps-0.53-0.37-1.69-2.10-2.15
eps diluted-0.53-0.37-1.69-2.10-2.15
weighted average shs out9.83M7.388M4.757M2.378M2.12M
weighted average shs out dil9.83M7.388M4.757M2.378M2.12M
Graph

PTPI Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents
short term investments
cash and short term investments
net receivables
inventory
other current assets
total current assets
property plant equipment net
goodwill
intangible assets
goodwill and intangible assets
long term investments
tax assets
other non current assets
total non current assets
other assets
total assets
account payables
short term debt
tax payables
deferred revenue
other current liabilities
total current liabilities
long term debt
deferred revenue non current
deferred tax liabilities non current
other non current liabilities
total non current liabilities
other liabilities
capital lease obligations
total liabilities
preferred stock
common stock
retained earnings
accumulated other comprehensive income loss
other total stockholders equity
total stockholders equity
total equity
total liabilities and stockholders equity
minority interest
total investments
total debt
net debt
Graph

PTPI Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-5.369M-1.901M-41.019K
stock based compensation116.834K290.381K212.738K30.84K43.316K
change in working capital-278.788K1.756M1.624M-1.791M1.134M
accounts receivables154.706K320.266K753.156K-426.305K-145.37K
inventory128.618K12.815K336.802K-96.457K88.358K
accounts payables-1.346M424.00K358.19K-428.67K-74.622K
other working capital784.052K971.388K176.031K-839.452K1.266M
other non cash items1.096M-759.692K19.617K3.692M11.52K
net cash provided by operating activities-1.662M-1.135M-2.26M-3.692M-572.07K
investments in property plant and equipment2.000000
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites00000
debt repayment-379.791K0-374.179K-368.649K-363.201K
common stock issued00011.089M0
common stock repurchased-1.579M-1.121M000
dividends paid0-601.12M000
other financing activites-1.958M-520.291K0368.649K-363.201K
net cash used provided by financing activities-1.958M-1.121M-2.373M11.089M-363.201K
effect of forex changes on cash00000
net change in cash-3.621M-2.256M-4.633M12.327K-935.271K
cash at end of period7.46M11.081M13.337M7.397M7.385M
cash at beginning of period11.081M13.337M17.97M7.385M8.32M
operating cashflow-1.662M-1.135M-2.26M-3.692M-572.07K
capital expenditure2.000000
free cash flow-1.662M-1.135M-2.26M-3.692M-572.07K
Graph

Frequently Asked Questions

How did Petros Pharmaceuticals, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, PTPI generated $1.58M in revenue last quarter, while its costs came in at $287.01K.

Last quarter, how much Gross Profit did Petros Pharmaceuticals, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Petros Pharmaceuticals, Inc. reported a $1.29M Gross Profit for the quarter ended Jun 30, 2024.

Have PTPI's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. PTPI incurred $2.89M worth of Operating Expenses, while it generated -$2.34M worth of Operating Income.

How much Net Income has PTPI posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Petros Pharmaceuticals, Inc., the company generated -$2.22M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Petros Pharmaceuticals, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Petros Pharmaceuticals, Inc. as of the end of the last quarter was -.

What are PTPI's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, PTPI had Total Net Receivables of -.

In terms of Total Assets and Current Assets, where did Petros Pharmaceuticals, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of PTPI were -, while the Total Assets stand at -.

As of the last quarter, how much Total Debt did Petros Pharmaceuticals, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of PTPI's debt was - at the end of the last quarter.

What were PTPI's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, PTPI reported total liabilities of -.

How much did PTPI's Working Capital change over the last quarter?

Working Capital Change for PTPI was -$278.79K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

PTPI generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. PTPI generated -$1.66M of Cash from Operating Activities during its recently reported quarter.

What was PTPI's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. PTPI reported a -$3.62M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph